Artron Laboratories Inc. was founded in 2002 by a team of dedicated and talented research scientists. Today, Artron has established itself as a global leader in the progression of in vitro diagnostic lateral flow tests that have revolutionized the market for disease diagnosis and analyte detection.
At Artron, we are devoted to excellence and innovation; we aspire to overcome industry challenges and provide simple and affordable IVD products that meet your highest expectations. The combination of an experienced research team along with a highly developed production technology guarantees that our tests are of premium quality. We have an extensive product catalogue that includes lateral flow tests (rapid diagnostics) for the detection of fertility hormones, infectious diseases, tumor markers, cardiac markers, drugs of abuse, food safety, and genetically modified organisms.
Artron's research and development facility in Burnaby, Canada is fully equipped with advanced technology for operating in the fields of Molecular Biology, Monoclonal Antibody Development, Protein Purification and Rapid Test Kit Development.
Artron specializes in the production of high quality rapid lateral flow tests for the detection of fertility hormones, tumor markers, drugs of abuse, cardiac markers, infectious diseases, food safety, and genetically modified organisms.
In addition to providing premium quality finished products with the highest accuracy and sensitivity, Artron also offers customization services. Our extremely capable design team utilizes advanced engineering techniques that enable us to customize products and tailor them to the individual needs of our clients. Our customization services include but are not limited to the development of custom-made lateral flow tests, monoclonal antibodies, critical membrane components, as well as OEM services.
Apart from these services, we are also a leading supplier for uncut sheets and bundles of unassembled test components like NC membranes, colloidal gold conjugates, and sample pads.